Scholars@Duke
Journal cover image

Re: A Double-Blind, Placebo Controlled, Randomized Phase 1 Cross-Over Study with ALLN-177, an Orally Administered Oxalate Degrading Enzyme.

Publication ,  Journal Article
Assimos, DG
Published in: J Urol
March 2017
Published version (DOI) Link to item

Duke Scholars

Dean George Assimos
Author Dean George Assimos Urology

Published In

J Urol

DOI

10.1016/j.juro.2016.12.033

EISSN

1527-3792

Publication Date

March 2017

Volume

197

Issue

3 Pt 1

Start / End Page

736 / 737

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • Oxalates
  • Double-Blind Method
  • Cross-Over Studies
  • Administration, Oral
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Assimos, D. G. (2017). Re: A Double-Blind, Placebo Controlled, Randomized Phase 1 Cross-Over Study with ALLN-177, an Orally Administered Oxalate Degrading Enzyme. J Urol, 197(3 Pt 1), 736–737. https://doi.org/10.1016/j.juro.2016.12.033
Assimos, Dean G. “Re: A Double-Blind, Placebo Controlled, Randomized Phase 1 Cross-Over Study with ALLN-177, an Orally Administered Oxalate Degrading Enzyme.” J Urol 197, no. 3 Pt 1 (March 2017): 736–37. https://doi.org/10.1016/j.juro.2016.12.033.
Assimos, Dean G. “Re: A Double-Blind, Placebo Controlled, Randomized Phase 1 Cross-Over Study with ALLN-177, an Orally Administered Oxalate Degrading Enzyme.” J Urol, vol. 197, no. 3 Pt 1, Mar. 2017, pp. 736–37. Pubmed, doi:10.1016/j.juro.2016.12.033.
Journal cover image

Published In

J Urol

DOI

10.1016/j.juro.2016.12.033

EISSN

1527-3792

Publication Date

March 2017

Volume

197

Issue

3 Pt 1

Start / End Page

736 / 737

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • Oxalates
  • Double-Blind Method
  • Cross-Over Studies
  • Administration, Oral
  • 3202 Clinical sciences
  • 1103 Clinical Sciences